Zoetis Inc. (NYSE:ZTS) Shares Acquired by Nilsine Partners LLC

Nilsine Partners LLC grew its stake in shares of Zoetis Inc. (NYSE:ZTS) by 4.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,846 shares of the company’s stock after acquiring an additional 1,151 shares during the quarter. Nilsine Partners LLC’s holdings in Zoetis were worth $4,537,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Berkshire Bank purchased a new position in shares of Zoetis in the fourth quarter worth $202,000. Baldwin Wealth Partners LLC MA increased its position in shares of Zoetis by 5.6% in the 4th quarter. Baldwin Wealth Partners LLC MA now owns 74,961 shares of the company’s stock valued at $12,213,000 after acquiring an additional 4,002 shares during the period. Kavar Capital Partners Group LLC raised its stake in Zoetis by 86.8% in the 4th quarter. Kavar Capital Partners Group LLC now owns 10,268 shares of the company’s stock worth $1,673,000 after acquiring an additional 4,772 shares during the last quarter. Pacer Advisors Inc. lifted its position in Zoetis by 12.4% during the 4th quarter. Pacer Advisors Inc. now owns 52,401 shares of the company’s stock worth $8,538,000 after acquiring an additional 5,790 shares during the period. Finally, Union Bancaire Privee UBP SA purchased a new stake in Zoetis during the 4th quarter valued at about $898,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Leerink Partners initiated coverage on shares of Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective for the company. JPMorgan Chase & Co. increased their price objective on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. UBS Group started coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price for the company. Finally, Stifel Nicolaus lowered their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $211.89.

Zoetis Stock Up 2.6 %

ZTS opened at $173.07 on Tuesday. The company has a market cap of $78.08 billion, a PE ratio of 32.53, a price-to-earnings-growth ratio of 2.57 and a beta of 0.89. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53. The company has a 50-day moving average price of $170.10 and a 200 day moving average price of $179.75. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping the consensus estimate of $1.46 by $0.12. The company had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s quarterly revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.36 EPS. Sell-side analysts expect that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.